- Home
- CGBD vs MDXG Comparison
CGBD vs MDXG Comparison
Compare CGBD & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CGBD | MDXG |
|---|---|---|
| Founded | 2012 | 2006 |
| Country | United States | United States |
| Employees | 2500 | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 741.0M | 625.6M |
| IPO Year | 2013 | 2007 |
Fundamental Metrics
Financial Performance| Metric | CGBD | MDXG |
|---|---|---|
| Price | $10.77 | $4.64 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 8 | 5 |
| Target Price | ★ $12.50 | $7.40 |
| AVG Volume (30 Days) | 297.5K | ★ 899.5K |
| Earning Date | 11-03-2026 | 10-28-2026 |
| Dividend Yield | ★ 15.44% | N/A |
| EPS Growth | N/A | ★ 14.29 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $418,630,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.37 | $21.78 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 19.99 |
| 52 Week Low | $9.95 | $3.03 |
| 52 Week High | $13.28 | $7.97 |
Technical Indicators
Market Signals| Indicator | CGBD | MDXG |
|---|---|---|
| Relative Strength Index (RSI) | 35.57 | 54.58 |
| Support Level | $10.53 | $4.11 |
| Resistance Level | $10.79 | $4.76 |
| Average True Range (ATR) | 0.22 | 0.16 |
| MACD | -0.10 | -0.02 |
| Stochastic Oscillator | 9.05 | 47.46 |
Price Performance
Historical ComparisonAbout CGBD Carlyle Secured Lending Inc.
Carlyle Secured Lending Inc is a specialty finance company that is a closed-end, externally managed, non-diversified management investment company. It focuses on providing directly originated, financing solutions across the capital structure, with a focus on senior secured lending to middle-market companies located in the United States. The company's investment objective is to generate current income and capital appreciation through debt investments in U.S. middle-market companies.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.